Lexicon Pharmaceuticals
LXRX
#8213
Rank
NZ$0.31 B
Marketcap
$0.86
Share price
1.96%
Change (1 day)
-68.68%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$1.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.14. In 2022 the company made an earnings per share (EPS) of -$1.03 an increase over its 2021 EPS that were of -$1.03.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.118.33%
2022-$1.03-0%
2021-$1.0310.91%
2020-$0.93-145.08%
2019$2.05-206.09%
2018-$1.94-5.74%
2017-$2.05-10.95%
2016-$2.312640%
2015-$0.08415-96.34%
2014-$2.30-2.53%
2013-$2.36-9.09%
2012-$2.59-37.14%
2011-$4.120%
2010-$4.12-39.66%
2009-$6.833.57%
2008-$6.60-8.2%
2007-$7.19-24.69%
2006-$9.5442.11%
2005-$6.72-22.97%
2004-$8.72-35.09%
2003-$13.43-0%
2002-$13.4362.86%
2001-$8.25-19.54%
2000-$10.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.49 729.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$62.88-5,594.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.23 1,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.31-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.82-2,355.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.75 314.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-$44.78 3,813.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.64-330.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.26 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA